Vitamin D3 Receptor (VDR) Gene rs2228570 (Fok1) and rs731236 (Taq1) Variants Are Not Associated with the Risk for Multiple Sclerosis: Results of a New Study and a Meta-Analysis-Reference-Cited by-同舟云学术

Vitamin D3 Receptor (VDR) Gene rs2228570 (Fok1) and rs731236 (Taq1) Variants Are Not Associated with the Risk for Multiple Sclerosis: Results of a New Study and a Meta-Analysis

Published:2013-06-20 Issue:6 Volume:8 Page:e65487
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

García-Martín Elena,Agúndez José A. G.,Martínez Carmen,Benito-León Julián,Millán-Pascual Jorge,Calleja Patricia,Díaz-Sánchez María,Pisa Diana,Turpín-Fenoll Laura,Alonso-Navarro Hortensia,Ayuso-Peralta Lucía,Torrecillas Dolores,Plaza-Nieto José Francisco,Jiménez-Jiménez Félix Javier

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference30 articles.

1. Genetics of multiple sclerosis: linkage and association studies;M Giordano;Am J Pharmacogenomics,2002

2. Genetics of multiple sclerosis;DA Dyment;Lancet Neurol,2004

3. The genetics of clinical outcome in multiple sclerosis;SV Ramagopalan;J Neuroimmunol,2008

4. Pugliatti M, Harbo HF, Holmøy T, Kampman MT, Myhr KM, et al.. (2008) Environmental risk factors in multiple sclerosis. Acta Neurol Scand Suppl 188: 34–40.

5. Memory decline evolves independently of disease activity in MS;B Duque;Mult Scler,2008

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of genetic variants related to vitamin D and autoimmunity: A systematic review;Heliyon;2024-04

2. Vitamin D and the epidemiology of multiple sclerosis;Feldman and Pike's Vitamin D;2024

3. A review of the critical role of vitamin D axis on the immune system;Experimental and Molecular Pathology;2023-08

4. Association between LAG3/CD4 Genes Variants and Risk for Multiple Sclerosis;International Journal of Molecular Sciences;2022-12-03

5. Association of vitamin D receptor polymorphisms with vitamin D and calcium levels in Turkish multiple sclerosis patients;Neurodegenerative Disease Management;2022-12